ScholarWorks@Korea University College of Medicine: Park, Hong Seok

Detailed Information

Park, Hong Seok (박홍석)

Guro Hospital (Department of Urology, Guro Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Prostatic neoplasms:4||Bladder:4||Renal cell carcinoma:3||Obesity:3||Biopsy:3||prostate cancer:3||Metabolic Health:2||Penile induration:2||Urinary tract infection:2||recurrence:2||Angiomyolipoma:2||Urodynamic Parameters:2||resistance:2||Metabolically Healthy Obese:2||Metabolically Obese Normal Weight:2||NVPBEZ235:2||Primary Health Care:2||Prognosis:2||Prostate:2||immunohistochemistry:2||Suicide:2||Prostate Cancer:2||Prostatespecific antigen:2||Hunner Lesion:2||transitional cell carcinoma:2||Diagnosis:2||benign prostatic hyperplasia:2||Bladder Pain Syndrome:2||Escherichia coli:2||Interstitial Cystitis:2||carcinoma:2||Tuberous sclerosis:2||Recurrence:2||Bladder cancer:2||prognosis:2||Referral and Consultation Psychiatry:2||Cryosurgery:2||Urinary bladder:2||Chronic Disease:2||Female:2||Partial nephrectomy:2||Extended spectrum betalactamase:1||Extendedspectrum betalactamase:1||Fixeddose:1||Fluid intake:1||Focal adhesions:1||Forecasting:1||GEMCITABINE:1||GNRH TYPE 1 RECEPTOR:1||GONADOTROPINRELEASING HORMONE (GNRH) AGONIST:1||Gemcitabine:1||Gemcitiabine:1||HORMONE THERAPY:1||Heating pad:1||Heterotrophic bone formation:1||Histopathology:1||INTRAVESICAL CHEMOIMMUNOTHERAPY:1||Impotence:1||Infections:1||Intrauterine device:1||Intravesical installation:1||Invasion:1||Kidney:1||Kidney collecting tubules:1||Kidney neoplasms:1||LEUPROLIDE:1||Laminin 332:1||Leiomyoma:1||Life Support Care:1||Life support care:1||Longitudinal study:1||Lymphangioleiomyomatosis:1||Magnetics:1||Medication persistence:1||Metaanalysis:1||Metabolic health:1||Neoplasm invasiveness:1||Nephrectomy:1||Organ preservation:1||Osteopontin:1||PERFORMANCE:1||PROSTATE CANCER:1||PSA:1||PSATZ:1||Pain:1||Palliative Care:1||Papaverine:1||Pelvic pain:1||Perirenal hemorrhage:1||Phentolamine:1||Pheochromocytoma:1||Physicians Order for LifeSustaining Treatment:1||Probability sample:1||Prostate Neoplasms:1||Prostate cancer antigen 3:1||Prostatectomy:1||Pyuria:1||RECURRENCE RATE:1||RENAL PELVIS:1||Rat:1||Recurrent UTI:1||Renal tumor:1||Renal vein thrombus:1||Robotics:1||SUPERFICIAL BLADDER CANCER:1||SURGERY:1||Sepsis:1||Sexual behavior:1||Sexual health:1||Shared Decision Making:1||Shock:1||Sleep Deprivation:1||South Korea:1||Sperm Count:1||Sperm Motility:1||TCDD:1||Tadalafil:1||Tamsulosin:1||Terminal care:1||Terminally ill:1||Testosterone:1||Therapy:1||Transrectal:1||Transrectal prostate biopsy:1||Treatment outcome:1||Ultrasonography:1||Ureteral stone:1||Ureteroscopic lithotripsy:1||Urethra:1||Uric acid stone:1||Urinary bladder neck obstruction:1||Urinary bladder neoplasm:1||Urinary bladder neoplasms:1||Urinary retention:1||Urinary stone:1||Urinary tract infections:1||Urologic neoplasms:1||Urothelial carcinoma:1||Urothelial cell carcinoma:1||Uterine prolapse:1||VALIDATION:1||Wunderlich syndrome:1||acute urinary retention:1||adenovirus:1||adrenergic alphaantagonist:1||androgen ablation therapy:1||anxiety:1||augmentation:1||automatic device:1||bcl2:1||bcl6:1||bladder cancer:1||bladder dysfunction:1||bladder neoplasm:1||catheterization:1||cicatrix:1||cisplatin:1||combination:1||cryoablation for the prostate:1||cryosurgery:1||difficult ureter:1||disease progression:1||docetaxel:1||drug therapy:1||erection:1||experimental animal model:1||experimental study:1||extracorporeal magnetic innervation:1||extragastrointestinal stromal tumor:1||fever:1||functional bladder capacity:1||gene therapy:1||glans penis:1||hormone antagonist:1||hyaluronic acid:1||hydronephrosis:1||intermittent cathterization:1||interventional procedures:1||intravesical instillation:1||learning curve:1||low maximal flow rate:1||luminescence:1||magnetic resonance imaging:1||microRNA:1||mutation:1||nanoparticles:1||nocturnal enuresis:1||outcomes assessment:1||pain:1||penis:1||photodynamic therapy:1||photons:1||polymerase chain:1||prostatespecific antigen:1||prostatic cancer:1||prostatic hyperplasia:1||prostatic intraepithelial neoplasia:1||prostatic neoplasm:1||quality of life:1||radical prostatectomy:1||radiotherapy:1||reactionsinglestand conformation polymorphism:1||renal cell:1||renal cell carcinoma:1||rigid ureteroscopic lithotripsy:1||risk factors:1||robotics:1||screening test:1||scrotum:1||septic:1||sling:1||stress urinary incontinence:1||sunitinib:1||tamsulosin:1||targetedcryosurgical ablation of the prostate:1||technetium Tc 99m dimercaptosuccinic acid:1||technetium Tic 99m dimercaptosuccinic acid:1||thermotherapy:1||tumourinfiltrating lymphocytes:1||upconversion:1||upper extremity disability:1||ureter:1||urinary bladder:1||urinary tract infections:1||urodynamics:1||vesicoureteral reflux:1||zinc:1||유전자요법:1||231076:1||전립선암:1||4Aminobenzoic acid:1||Abiraterone acetate:1||Actinomycosis:1||Acute prostatitis:1||Adults:1||Advance directives:1||Adverse effects:1||Alprostadil:1||Amikacin:1||Amoxiclavulanate:1||Anxiety:1||Asian Continental Ancestry Group:1||BCG:1||BCL6:1||Betaadrenoceptor:1||Betalactam resistance:1||Bladder outlet obstruction:1||Bladder stone:1||CELL PROLIFERATION:1||Calyceal diverticular stone:1||Carcinoma:1||Chronic kidney disease:1||Clear cell renal carcinoma:1||Computed tomography:1||Condyloma acuminata:1||Corticosterone:1||Cystitis:1||Cystoscopy:1||Cytosine deaminase:1||DU145 CELLS:1||Diet:1||Distress:1||Docetaxel:1||Drug therapy:1||EORTC QLQC30:1||ESWL:1||EndofLife Discussion:1||Enterobacteriaceae:1||EpsteinBarr virus infections:1||Eversion:1||

STATISTICS: Total View :12,965,067; Today View :171

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE